http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010229039-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cc87d476fde0ce82ac3b7245e61b785 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
filingDate | 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6bdcf6cda031a5581382299cca520bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e43ae7c07a59527beb7a622c0ee88f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89c15a9125e840f04357b90632cd607a |
publicationDate | 2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2010229039-A |
titleOfInvention | Glyoxalase I inhibitor |
abstract | A glyoxalase I inhibitor having a novel skeleton different from a glutathione derivative and having high specificity for human glyoxalase I is provided. The present invention provides a glyoxalase I inhibitor and an anticancer agent represented by a predetermined general formula. The glyoxalase I inhibitor and anticancer agent of the present invention can inhibit the activity of human glyoxalase I with high specificity. For this reason, it can utilize effectively as a therapeutic agent of various diseases, such as an anticancer agent and an osteoporosis therapeutic agent. [Selection] Figure 10 |
priorityDate | 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.